Acute Phase Proteins
Detection of hereditary decreases in the production of α1-antitrypsin (α1AT). Decreased or nearly absent levels of α1AT can be a factor in chronic obstructive lung disease and liver disease. An increased prevalence of non-MM phenotypes is found with cryptogenic cirrhosis and with CAH. Cirrhosis in a child should raise consideration of α1AT deficiency or Wilson’s disease. Diagnosis of inflammatory states, if elevated (eg, rheumatoid arthritis, bacterial infection, vasculitis, neoplasia).
Additional Test Information:
Should be run when α1-globulin in serum protein electrophoresis is low or when two bands are seen in the α1-region. Heterozygous patients exhibit AAT levels which are commonly about 60% of normal. Homozygous recessive α1AT patients exhibit levels at about 10% of normal. Phenotyping is desirable on patients with low values and on all patients being worked up for AAT-deficient liver disease. Most pathologic is homozygous state ZZ. An M null genotype will have phenotype as MM but low serum level. AAT is one of the alpha-globulins, which together are called “acute phase reactants.” These rise rapidly, but nonspecifically, in response to inflammatory insults.
Serum or plasma
0.5 mL (Note: This volume does not allow for repeat testing.)
Red-top tube, gel-barrier tube, lavender-top (EDTA) tube, or green-top (heparin) tube
Separate serum or plasma from cells.
Maintain specimen at room temperature.
Return Back to Test Directory
Providing top patient care with fast results.
7018 South Utica Avenue
Tulsa, Oklahoma 74136